Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;308(4):1279-1286.
doi: 10.1007/s00404-022-06773-0. Epub 2022 Oct 27.

Relationship between risk factor profile and prescription of low-dose aspirin for preeclampsia prevention

Alexandra J D Phelps  1 , Calla Holmgren  2
Affiliations

Relationship between risk factor profile and prescription of low-dose aspirin for preeclampsia prevention

Alexandra J D Phelps et al. Arch Gynecol Obstet. 2023 Oct.

Abstract

Objective: The purpose of this study was to assess obstetrician-gynecologist utilization of low-dose aspirin for women at increased risk for hypertensive disorders of pregnancy using guidelines developed by the American College of Obstetricians and Gynecologists and supported by the United States Preventive Services Task Force. Further, the study evaluated prescribing practices in relation to specific risk factor profiles to identify which women are at highest risk of not receiving recommended therapy.

Methods: This was a retrospective cohort study reviewed and approved by the local Institutional Review Board. Electronic health records of women with singleton pregnancies who delivered between February and August 2020 were reviewed to identify risk factors for preeclampsia. Women were eligible for aspirin prophylaxis if they had at least one "high" risk factor or multiple "moderate" risk factors, as defined by the United States Preventive Services Task Force guidelines. Associations of interest were addressed using Pearson Chi-squared tests and multinomial logistic regression.

Results: 970 patients were included and 301 pregnant persons (31%) met criteria for low-dose aspirin prophylaxis; of these, 92 (31%) were given this recommendation. Those eligible for prophylaxis by presence of multiple "moderate" risk factors alone are least likely (0-6%) to receive indicated aspirin prophylaxis.

Conclusions for practice: Low-dose aspirin is an underutilized tool for preventing preeclampsia. Women with a combination of "moderate" risk factors are most likely to not receive indicated aspirin prophylaxis. Efforts should be made to encourage broader uptake of the recommendations for aspirin prophylaxis among obstetrician-gynecologists.

Significance: What is already known on this subject? Low-dose aspirin has been shown to reduce preeclampsia risk in pregnant persons. This preventive measure has been recommended by most national and international organizations including the American College of Obstetricians and Gynecologists and the United States Preventive Services Task Force. Yet despite widespread support of this recommendation, uptake is not universal among obstetric care providers. What this study adds? This study identifies those who are most likely to experience a missed opportunity for aspirin prophylaxis, thus providing a suggestion for where provider education or other efforts to increase adherence to this guideline may be most impactful.

Keywords: Low-dose aspirin; Preeclampsia; Prescriber practices; Prevention.

PubMed Disclaimer

References

    1. Abalos E, Cuesta C, Grosso AL, Chou D, Say L (2013) Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol 170(1):1–7. https://doi.org/10.1016/j.ejogrb.2013.05.005 - DOI - PubMed
    1. American College of Obstetricians and Gynecologists (2018) ACOG committee opinion no. 743: low-dose aspirin use during pregnancy. Obstet Gynecol 132(1):e44–e52. https://doi.org/10.1097/AOG.0000000000002708 - DOI
    1. American College of Obstetricians and Gynecologists (2020) Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222. Obstet Gynecol 135(6):e237–e260. https://doi.org/10.1097/AOG.0000000000003891 - DOI
    1. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA (2007) Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369(9575):1791–1798. https://doi.org/10.1016/S0140-6736(07)60712-0 - DOI - PubMed
    1. Banala C, Moreno S, Cruz Y, Boelig RC, Saccone G, Berghella V, Schoen CN, Roman A (2020) Impact of the ACOG guideline regarding low-dose aspirin for prevention of superimposed preeclampsia in women with chronic hypertension. Am J Obstet Gynecol 223(3):419.e1-419.e16. https://doi.org/10.1016/j.ajog.2020.03.004 - DOI - PubMed

LinkOut - more resources